• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Hvivo PLC (HVO)

ORD 0.1P
Sell: 7.40p|Buy: 7.60p|Change: 0.30 (4.17%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

This investment is listed on the Alternative Investment Market (AIM). Investments on this market can be higher risk and have lower liquidity, meaning they can be harder to buy or sell, and their prices may be more volatile. Before investing, make sure you understand the risks of investing.

Company profile

hVIVO PLC is a full-service early phase Contract Research Organisation (CRO). It delivers end-to-end clinical development services to a diverse and expanding client base. The group specialises in conducting human challenge trials across multiple infectious and respiratory indications. It also offers comprehensive virology and immunology laboratory services under the hLAB brand. Through its subsidiary, it provides early-phase clinical trial services and Early Drug DevelopmentConsulting and Biometry services to the biopharma sector. It provides development solutions from preclinical stages through Phase II trials, via FluCamp. Additionally, its five clinical sites support outpatient Phase II and III trials, ensuring a seamless and efficient pathway from discovery to late-stage development.

Address

1 Berkeley Street
London
GBR
W1J 8DJ

Telephone

+353 15373269

Website

https://www.hvivo.com

Sector 

Healthcare

Forecast key dates

NameKey Date
hVIVO PLC Annual Report for 20262027-04-16T00:00:00
hVIVO PLC Fourth Quarter Earnings Conference Call for 20262027-04-15T10:00:00
hVIVO PLC Fourth Quarter Earnings Results for 20262027-04-15T00:00:00
hVIVO PLC Second Quarter Earnings Conference Call for 20262026-09-23T17:00:00
hVIVO PLC Second Quarter Earnings Results for 20262026-09-23T00:00:00
hVIVO PLC Annual General Meeting for 20252026-05-13T10:00:00
hVIVO PLC Annual Report for 20252026-04-17T00:00:00
hVIVO PLC Fourth Quarter Earnings Conference Call for 20252026-04-15T10:00:00
hVIVO PLC Fourth Quarter Earnings Result for 20252026-04-15T00:00:00

Previous key dates

NameKey Date
hVIVO PLC Annual Report for 20252026-04-17T00:00:00
hVIVO PLC Fourth Quarter Earnings Conference Call for 20252026-04-15T10:00:00
hVIVO PLC Fourth Quarter Earnings Result for 20252026-04-15T00:00:00
hVIVO PLC Second Quarter Earnings Conference Call for 20252025-09-23T17:00:00
hVIVO PLC Second Quarter Earnings Result for 20252025-09-23T00:00:00
hVIVO PLC Annual General Meeting for 20242025-06-05T11:00:00
hVIVO PLC Annual Report for 20242025-05-01T00:00:00
hVIVO PLC Fourth Quarter Earnings Conference Call for 20242025-04-10T11:00:00
hVIVO PLC Fourth Quarter Earnings Result for 20242025-04-10T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.